Results 111 to 120 of about 13,459 (185)

Engineering systemic oncolytic virotherapy through immune-compatible delivery and programmable tumor cell death. [PDF]

Mol Ther Oncol
Chen X, Chen Y, Ping Y.
europepmc   +1 more source

Precision virotherapies: Coming soon

Oncotarget, 2018
Uusi-Kerttula, Hanni, Parker, Alan L.
openaire   +2 more sources

Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virus. [PDF]

Mol Ther Oncol
Boulton S, Singh S, Bell JC.
europepmc   +1 more source

Retraction: Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. [PDF]

Cancer Immunol Res
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M.   +14 more
europepmc   +1 more source

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy. [PDF]

Cureus
BinSharhan AS, AlAbdullah AM, Alabdullatif SF, Aboushark YY, Alateeq NM, Alhajjaj WA, Alrabea HO, Saeedi F.   +7 more
europepmc   +1 more source

Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. [PDF]

J Neurooncol
Elgehiny A, Fan AE, Frost M, He J, Gary SE, Osorio DS, Zaky W, Zhou L, Kang KD, Zhang Z, Fueyo J, Gomez-Manzano C, Thompson EM, Bernstock JD, Friedman GK.   +14 more
europepmc   +1 more source

Strategically engineering an oncolytic herpes simplex virus to improve systemic delivery. [PDF]

Mol Ther Oncol
Fu X, Benedyk T, Zhang SX.
europepmc   +1 more source

A comprehensive review redefining viruses as therapeutic agents in cancer treatment. [PDF]

Discov Oncol
Jadhav A, J A, Patel T.
europepmc   +1 more source

Targeting collagen to enhance oncolytic virotherapy outcome in gastric cancer patients. [PDF]

Mol Ther Oncol
Soni H.
europepmc   +1 more source